Journal Article

FZJ-2023-04232

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png New prodigiosin derivatives – chemoenzymatic synthesis and physiological evaluation against cisplatin-resistant cancer cells

Weber, T. M. ; Leyens, A.FZJ* ; Berning, L. ; Stork, B. ; Pietruszka, J. (Corresponding author)FZJ*

2023
RSC Publ. London

This record in other databases:  

Please use a persistent id in citations: doi:10.1039/D3CY00913K  doi:10.34734/FZJ-2023-04232

---

Contributing Institute(s):

1. Institut für Bioorganische Chemie (HHUD) (IBOC)
2. Biotechnologie (IBG-1)

Research Program(s):

1. 2171 - Biological and environmental resources for sustainable use (POF4-217) (POF4-217)
2. GRK 2158 - GRK 2158: Naturstoffe und Analoga gegen Therapie-resistente Tumoren und Mikroorganismen: Neue Leitstrukturen und Wirkmechanismen (270650915) (270650915)

Appears in the scientific report 2023

---

Database coverage:
; ; ; Clarivate Analytics Master Journal List ; Current Contents - Physical, Chemical and Earth Sciences ; Essential Science Indicators ; IF >= 5 ; JCR ; Nationallizenz ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection

---